Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease. It is an application of the fundamental research of cancer immunology and a growing subspeciality of oncology. Cancer immunotherapy exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g., carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Cancer Immunotherapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segment by Product Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Cancer Immunotherapy consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Cancer Immunotherapy market by identifying its various subsegments.
3.Focuses on the key global Cancer Immunotherapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cancer Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cancer Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Cancer Immunotherapy Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Cancer Immunotherapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Cancer Immunotherapy Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Immune Checkpoint Inhibitors
2.1.3 Immune System Modulators
2.1.4 Cancer Vaccines
2.2 Market Analysis by Application
2.2.1 Lung Cancer
2.2.2 Breast Cancer
2.2.3 Colorectal Cancer
2.2.4 Melanoma
2.2.5 Prostate Cancer
2.2.6 Others
2.3 Global Cancer Immunotherapy Market Comparison by Regions (2017-2027)
2.3.1 Global Cancer Immunotherapy Market Size (2017-2027)
2.3.2 North America Cancer Immunotherapy Status and Prospect (2017-2027)
2.3.3 Europe Cancer Immunotherapy Status and Prospect (2017-2027)
2.3.4 China Cancer Immunotherapy Status and Prospect (2017-2027)
2.3.5 Japan Cancer Immunotherapy Status and Prospect (2017-2027)
2.3.6 Southeast Asia Cancer Immunotherapy Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapy Industry Impact
2.5.1 Cancer Immunotherapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Cancer Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Cancer Immunotherapy Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Cancer Immunotherapy Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Cancer Immunotherapy Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Cancer Immunotherapy Manufacturer Market Share
3.5 Top 10 Cancer Immunotherapy Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Cancer Immunotherapy Market
3.7 Key Manufacturers Cancer Immunotherapy Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Cancer Immunotherapy Industry Key Manufacturers
4.1 Amgen
4.1.1 Compan Detail
4.1.2 Amgen Cancer Immunotherapy Product Introduction, Application and Specification
4.1.3 Amgen 136 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 AstraZeneca
4.2.1 Compan Detail
4.2.2 AstraZeneca Cancer Immunotherapy Product Introduction, Application and Specification
4.2.3 AstraZeneca Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Amgen News
4.3 Roche
4.3.1 Compan Detail
4.3.2 Roche Cancer Immunotherapy Product Introduction, Application and Specification
4.3.3 Roche Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Roche News
4.4 Bayer
4.4.1 Compan Detail
4.4.2 Bayer Cancer Immunotherapy Product Introduction, Application and Specification
4.4.3 Bayer Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bayer News
4.5 Bristol-Myers Squibb
4.5.1 Compan Detail
4.5.2 Bayer Cancer Immunotherapy Product Introduction, Application and Specification
4.5.3 Bristol-Myers Squibb Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Bristol-Myers Squibb News
4.6 Eli Lilly
4.6.1 Compan Detail
4.6.2 Eli Lilly Cancer Immunotherapy Product Introduction, Application and Specification
4.6.3 Eli Lilly Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Eli Lilly News
4.7 Merck
4.7.1 Compan Detail
4.7.2 Merck Cancer Immunotherapy Product Introduction, Application and Specification
4.7.3 Merck Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Novartis
4.8.1 Compan Detail
4.8.2 Novartis Cancer Immunotherapy Product Introduction, Application and Specification
4.8.3 Novartis Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Novartis News
4.9 Pfizer
4.9.1 Compan Detail
4.9.2 Pfizer Cancer Immunotherapy Product Introduction, Application and Specification
4.9.3 Pfizer Cancer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Pfizer News
5 Global Cancer Immunotherapy Market Segment by Big Type
5.1 Global Cancer Immunotherapy Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Cancer Immunotherapy Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Cancer Immunotherapy Revenue and Market Share by Big Type (2017-2022)
5.2 Monoclonal Antibodies Sales Growth Rate and Price
5.2.1 Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
5.2.2 Global Monoclonal Antibodies Price (2017-2022)
5.3 Immune Checkpoint Inhibitors Sales Growth Rate and Price
5.3.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2017-2022)
5.3.2 Global Immune Checkpoint Inhibitors Price (2017-2022)
5.4 Immune System Modulators Sales Growth Rate and Price
5.4.1 Global Immune System Modulators Sales Growth Rate (2017-2022)
5.4.2 Global Immune System Modulators Price (2017-2022)
5.5 Cancer Vaccines Sales Growth Rate and Price
5.5.1 Global Cancer Vaccines Sales Growth Rate (2017-2022)
5.5.2 Global Cancer Vaccines Price (2017-2022)
6 Global Cancer Immunotherapy Market Segment by Big Application
6.1 Global Cancer Immunotherapy Sales Market Share by Big Application (2017-2022)
6.2 Lung Cancer Sales Growth Rate (2017-2022)
6.3 Breast Cancer Sales Growth Rate (2017-2022)
6.4 Colorectal Cancer Sales Growth Rate (2017-2022)
6.5 Melanoma Sales Growth Rate (2017-2022)
6.6 Prostate Cancer Sales Growth Rate (2017-2022)
6.7 Others Sales Growth Rate (2017-2022)
7 Global Cancer Immunotherapy Forecast
7.1 Global Cancer Immunotherapy Revenue, Sales and Growth Rate (2022-2027)
7.2 Cancer Immunotherapy Market Forecast by Regions (2022-2027)
7.2.1 North America Cancer Immunotherapy Market Forecast (2022-2027)
7.2.2 Europe Cancer Immunotherapy Market Forecast (2022-2027)
7.2.3 China Cancer Immunotherapy Market Forecast (2022-2027)
7.2.4 Japan Cancer Immunotherapy Market Forecast (2022-2027)
7.2.5 Southeast Asia Cancer Immunotherapy Market Forecast (2022-2027)
7.2.6 Other Regions Cancer Immunotherapy Market Forecast (2022-2027)
7.3 Cancer Immunotherapy Market Forecast by Type (2022-2027)
7.3.1 Global Cancer Immunotherapy Sales Forecast by Type (2022-2027)
7.3.2 Global Cancer Immunotherapy Market Share Forecast by Type (2022-2027)
7.4 Cancer Immunotherapy Market Forecast by Application (2022-2027)
7.4.1 Global Cancer Immunotherapy Sales Forecast by Application (2022-2027)
7.4.2 Global Cancer Immunotherapy Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Cancer Immunotherapy Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Cancer Immunotherapy Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Cancer Immunotherapy
Figure Market Concentration Ratio and Market Maturity Analysis of Cancer Immunotherapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Cancer Immunotherapy Market Size by Big Type
Figure Global Market Share of Cancer Immunotherapy by Big Type in 2021
Figure Monoclonal Antibodies Picture (2017-2022)
Figure Immune Checkpoint Inhibitors Picture (2017-2022)
Figure Immune System Modulators Picture (2017-2022)
Global Cancer Immunotherapy Market Size by Big Application
Table Global Cancer Immunotherapy Market Size by Application
Figure Global Cancer Immunotherapy Market Share by Big Application in 2021
Figure Lung Cancer Picture
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Others Picture
Table Global Cancer Immunotherapy Comparison by Regions (M USD) (2017-2027)
Figure Global Cancer Immunotherapy Market Size (Million US$) (2017-2027)
Figure North America Cancer Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Cancer Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure China Cancer Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Cancer Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Cancer Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Cancer Immunotherapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Cancer Immunotherapy Sales by Manufacturer (2017-2022)
Figure Global Cancer Immunotherapy Sales Market Share by Manufacturer in 2021
Table Global Cancer Immunotherapy Revenue by Manufacturer (2017-2022)
Figure Global Cancer Immunotherapy Revenue Market Share by Manufacturer in 2021
Table Global Cancer Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Cancer Immunotherapy Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Cancer Immunotherapy Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Cancer Immunotherapy Market
Table Key Manufacturers Cancer Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table Amgen Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Amgen
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AstraZeneca Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of AstraZeneca
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Recent Development
Table Roche Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Roche
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Bayer Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Bayer
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Bayer Main Business
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Eli Lilly
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Merck Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Merck
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Novartis Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Novartis
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Pfizer Company Profile
Table Cancer Immunotherapy Product Introduction, Application and Specification of Pfizer
Table Cancer Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Figure Global Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure Global Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
Table Global Cancer Immunotherapy Sales by Regions (2017-2022)
Figure Global Cancer Immunotherapy Sales Market Share by Regions in 2021
Table Global Cancer Immunotherapy Revenue by Regions (2017-2022)
Figure Global Cancer Immunotherapy Revenue Market Share by Regions in 2021
Figure North America Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure Europe Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure China Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure Japan Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Figure Other Regions Cancer Immunotherapy Sales and Growth Rate (2017-2022)
Table Global Cancer Immunotherapy Sales by Big Type (2017-2022)
Table Global Cancer Immunotherapy Sales Market Share by Big Type (2017-2022)
Figure Global Cancer Immunotherapy Sales Market Share by Big Type in 2019
Table Global Cancer Immunotherapy Revenue by Big Type (2017-2022)
Table Global Cancer Immunotherapy Revenue Market Share by Big Type (2017-2022)
Table Global Cancer Immunotherapy Revenue Market Share by Big Type in 2019
Figure Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibodies Price (2017-2022)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate (2017-2022)
Figure Global Immune Checkpoint Inhibitors Price (2017-2022)
Figure Global Immune System Modulators Sales Growth Rate (2017-2022)
Figure Global Immune System Modulators Price (2017-2022)
Figure Global Cancer Vaccines Sales Growth Rate (2017-2022)
Table Global Cancer Immunotherapy Sales by Big Application (2017-2022)
Table Global Cancer Immunotherapy Sales Market Share by Big Application (2017-2022)
Figure Global Cancer Immunotherapy Sales Market Share by Big Application in 2019
Figure Global Lung Cancer Sales Growth Rate (2017-2022)
Figure Global Breast Cancer Sales Growth Rate (2017-2022)
Figure Global Colorectal Cancer Sales Growth Rate (2017-2022)
Figure Global Melanoma Sales Growth Rate (2017-2022)
Figure Global Prostate Cancer Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Cancer Immunotherapy Sales and Growth Rate (2022-2027)
Figure Global Cancer Immunotherapy Revenue and Growth Rate (2022-2027)
Table Global Cancer Immunotherapy Sales Forecast by Regions (2022-2027)
Table Global Cancer Immunotherapy Market Share Forecast by Regions (2022-2027)
Figure North America Sales Cancer Immunotherapy Market Forecast (2022-2027)
Figure Europe Sales Cancer Immunotherapy Market Forecast (2022-2027)
Figure China Sales Cancer Immunotherapy Market Forecast (2022-2027)
Figure Japan Sales Cancer Immunotherapy Market Forecast (2022-2027)
Figure Southeast Asia Sales Cancer Immunotherapy Market Forecast (2022-2027)
Figure Other Regions Sales Cancer Immunotherapy Market Forecast (2022-2027)
Table Global Cancer Immunotherapy Sales Forecast by Type (2022-2027)
Table Global Cancer Immunotherapy Market Share Forecast by Type (2022-2027)
Table Global Cancer Immunotherapy Sales Forecast by Application (2022-2027)
Table Global Cancer Immunotherapy Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Cancer Immunotherapy Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Cancer Immunotherapy Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Cancer Immunotherapy Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Cancer Immunotherapy Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Cancer Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)